Enhancer ID: | E_01_0760 |
Species: | human |
Position : | chr11:67116871-67118871 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Mammary cancer |
Pubmed ID: | 30118678 |
Enhancer experiment: | RT-qPCR,GRO-seq,ChIP-seq,ChIP-qPCR ,weston blot,PRO-seq |
Enhancer experiment description: | Surprisingly, these basally-active estrogen-repressed (BAER) enhancers are decommissioned by ER?-dependent recruitment of the histone demethylase, KDM2A, functioning independently of its demethylase activity. While indirectly bound ER? recruits coactivators to these enhancers in a ligand-dependent fashion, the repression events, unexpectedly, reflect the availability of the ER? DNA binding domain (DBD) to interact with the histone demethylase, KDM2A, which, even in the absence of its demethylase function, serves to recruit the ubiquitin ligase NEDD4 to these enhancers, resulting ubiquitylation and dismissal of Pol II and consequent inhibition of these enhancer activities. |
Target gene : | KDM2A |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Surprisingly, these basally-active estrogen-repressed (BAER) enhancers are decommissioned by ER?-dependent recruitment of the histone demethylase, KDM2A, functioning independently of its demethylase activity. While indirectly bound ER? recruits coactivators to these enhancers in a ligand-dependent fashion, the repression events, unexpectedly, reflect the availability of the ER? DNA binding domain (DBD) to interact with the histone demethylase, KDM2A, which, even in the absence of its demethylase function, serves to recruit the ubiquitin ligase NEDD4 to these enhancers, resulting ubiquitylation and dismissal of Pol II and consequent inhibition of these enhancer activities. |
TF name : | -- |
TF experiment: | RT-qPCR,GRO-seq,ChIP-seq,ChIP-qPCR ,weston blot,PRO-seq |
TF experiment description: | Surprisingly, these basally-active estrogen-repressed (BAER) enhancers are decommissioned by ER?-dependent recruitment of the histone demethylase, KDM2A, functioning independently of its demethylase activity. While indirectly bound ER? recruits coactivators to these enhancers in a ligand-dependent fashion, the repression events, unexpectedly, reflect the availability of the ER? DNA binding domain (DBD) to interact with the histone demethylase, KDM2A, which, even in the absence of its demethylase function, serves to recruit the ubiquitin ligase NEDD4 to these enhancers, resulting ubiquitylation and dismissal of Pol II and consequent inhibition of these enhancer activities. |
Enhancer function : | Surprisingly, these basally-active estrogen-repressed (BAER) enhancers are decommissioned by ER?-dependent recruitment of the histone demethylase, KDM2A, functioning independently of its demethylase activity. While indirectly bound ER? recruits coactivators to these enhancers in a ligand-dependent fashion, the repression events, unexpectedly, reflect the availability of the ER? DNA binding domain (DBD) to interact with the histone demethylase, KDM2A, which, even in the absence of its demethylase function, serves to recruit the ubiquitin ligase NEDD4 to these enhancers, resulting ubiquitylation and dismissal of Pol II and consequent inhibition of these enhancer activities. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Surprisingly, these basally-active estrogen-repressed (BAER) enhancers are decommissioned by ER?-dependent recruitment of the histone demethylase, KDM2A, functioning independently of its demethylase activity. While indirectly bound ER? recruits coactivators to these enhancers in a ligand-dependent fashion, the repression events, unexpectedly, reflect the availability of the ER? DNA binding domain (DBD) to interact with the histone demethylase, KDM2A, which, even in the absence of its demethylase function, serves to recruit the ubiquitin ligase NEDD4 to these enhancers, resulting ubiquitylation and dismissal of Pol II and consequent inhibition of these enhancer activities. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|